TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Oncoimmunity AS
Closing information (x1000 EUR)
Closing information | 2020/03 | 2018/12 | 2017/12 |
Turnover | 1,356 | 849 | 527 |
Financial expenses | 356 | 5 | 0 |
Earnings before taxes | -3,134 | -772 | -309 |
Total assets | 4,573 | 6,031 | 1,156 |
Current assets | 4,547 | 5,986 | 1,092 |
Current liabilities | 888 | 184 | 141 |
Equity capital | 3,685 | 5,847 | 1,015 |
- share capital | 25 | 15 | 12 |
Employees (average) | 15 | ||
Shareholders | 0 | 0 | 0 |
Financial ratios
Fiscal year | 2020/03 | 2018/12 | 2017/12 |
Solvency | 80.6% | 96.9% | 87.8% |
Turnover per employee | 90 | ||
Profit as a percentage of turnover | -231.1% | -90.9% | -58.6% |
Return on assets (ROA) | -60.7% | -12.7% | -26.7% |
Current ratio | 512.0% | 3253.3% | 774.5% |
Return on equity (ROE) | -85.0% | -13.2% | -30.4% |
Change turnover | 619 | 332 | 246 |
Change turnover % | 84% | 64% | 88% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2020/03 | 2018/12 | 2017/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.